| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/16/2009 | WO2009087058A1 Process for the preparation of asenapine and intermediate products used in said process |
| 07/16/2009 | WO2009086705A1 Preparation method of rivastigmine, its intermediates and preparation method of the intermediates |
| 07/16/2009 | WO2009086591A1 Diagnostic and therapeutic methods for efmr (epilepsy and mental retardation limited to females) |
| 07/16/2009 | WO2009065946A3 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition |
| 07/16/2009 | WO2009058005A3 Unit dosage for brain health |
| 07/16/2009 | WO2009047770A3 Cytoplasmic malate dehydrogenase (mdh1) targeted treatment for neurodegenerative diseases |
| 07/16/2009 | WO2009046860A3 Use of dago as a therapeutic agent |
| 07/16/2009 | WO2009046859A3 Use of af12198 and dago as therapeutic agents |
| 07/16/2009 | WO2009043856A3 Modulation of tissue fatty acid composition of a host by human gut bacteria |
| 07/16/2009 | WO2009040035A3 Use of a peptide as a therapeutic agent |
| 07/16/2009 | WO2009039990A3 Use of icam peptide as a therapeutic agent |
| 07/16/2009 | WO2009039974A3 Use of peptide asp-arg-gly-asp-ser-oh as a therapeutic agent |
| 07/16/2009 | WO2009033817A3 Use of the combination of the hcv-1 e2 protein (484-499) and the human pancreatic polypeptide as a therapeutic agent |
| 07/16/2009 | WO2009033766A3 Use of a peptide as a therapeutic agent |
| 07/16/2009 | WO2009026653A8 Neuroplasticity assay |
| 07/16/2009 | WO2008153611A3 Sustained delivery formulations of risperidone compounds |
| 07/16/2009 | WO2008149354A3 Agents for the treatment of inflammatory diseases and methods of using same |
| 07/16/2009 | WO2008144394A3 Fused-ring heterocycle opioids |
| 07/16/2009 | WO2008068171A9 Substituted pyrimidines and their use as jnk modulators |
| 07/16/2009 | US20090182057 Deuterated aminoglycidal compounds |
| 07/16/2009 | US20090182056 Pharmaceutical formulations of amyloid inhibiting compounds |
| 07/16/2009 | US20090182048 Compounds Useful For Treating Neurological Disorders |
| 07/16/2009 | US20090182037 Cognitive Function |
| 07/16/2009 | US20090182036 Animal food composition comprising genistein and polyunsaturated fatty acids |
| 07/16/2009 | US20090182028 Plant Components and Extracts and Uses Thereof |
| 07/16/2009 | US20090182027 Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
| 07/16/2009 | US20090182026 Alpha 2 adrenergic agonists |
| 07/16/2009 | US20090182025 Substituted carboxamides |
| 07/16/2009 | US20090182024 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
| 07/16/2009 | US20090182023 Tricyclic compound and pharmaceutical use thereof |
| 07/16/2009 | US20090182021 Tricyclic Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease |
| 07/16/2009 | US20090182012 Piperidin-2, 6-dione pamoate salts and their use for the treatment of affective disorders |
| 07/16/2009 | US20090182011 Chimeric Nitrate Esters and Use of the Same in a Treatment for Depression |
| 07/16/2009 | US20090181999 Use of compositions containing kappa-opioid receptor antagonists for the treatment of dissociative disorders |
| 07/16/2009 | US20090181994 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 07/16/2009 | US20090181992 (s)-phenyl(heterocycle)methanol-based compounds, compositions comprising them and methods of their use |
| 07/16/2009 | US20090181985 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 07/16/2009 | US20090181984 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use |
| 07/16/2009 | US20090181982 Substituted pyrroline kinase inhibitors |
| 07/16/2009 | US20090181978 5-ht1a receptor subtype agonist |
| 07/16/2009 | US20090181974 Composition for slowing down the development of alzheimer's disease |
| 07/16/2009 | US20090181972 Novel Inhibitors of Cysteine Proteases, the Pharmaceutical Compositions Thereof and their Therapeutic Applications |
| 07/16/2009 | US20090181962 Substituted thiophene compounds |
| 07/16/2009 | US20090181954 Patches, formulations, and associated methods for transdermal delivery of alprazolam and other drugs |
| 07/16/2009 | US20090181953 Compound forms and uses thereof |
| 07/16/2009 | US20090181951 Parp inhibitors |
| 07/16/2009 | US20090181949 1h-imidazole derivative having cb1, agonistic, cb1 partial agonistic or cb1 antagnistic activity |
| 07/16/2009 | US20090181945 Two cyclic cinnamide compound |
| 07/16/2009 | US20090181932 COMPOSITIONS CONTAINING O-SULFATE AND O-PHOSPHATE CONTAINING ARYL SULFONAMIDE DERIVATIVES USEFUL AS beta-AMYLOID INHIBITORS |
| 07/16/2009 | US20090181920 Intrathecal treatment of neuropathic pain with a2ar agonists |
| 07/16/2009 | US20090181898 Abuse-resistant amphetamine prodrugs |
| 07/16/2009 | US20090181890 Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders |
| 07/16/2009 | US20090181887 Use of a glp-1 molecule for treatment of biliary dyskinesia and/or biliary pain/discomfort |
| 07/16/2009 | US20090181109 Nanoveson™: treatment, biomarkers and diagnostic tests for liver diseases and comorbid diseases |
| 07/16/2009 | US20090181100 Dry powder aerosols of Nanoparticulate drugs |
| 07/16/2009 | US20090181081 Systemic Treatment of Pathological Conditions Resulting From Oxidative Stress and/or Redox Imbalance |
| 07/16/2009 | US20090181069 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 07/16/2009 | US20090181064 Xenotransplant for cns therapy |
| 07/16/2009 | US20090181040 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans |
| 07/16/2009 | US20090181026 Tomoregulin-2-antibody compositions and methods for the diagnosis and treatment of Alzheimer's disease |
| 07/16/2009 | US20090181008 Methods of treating alzheimer's disease |
| 07/16/2009 | US20090181006 Methods for diagnosing and treating cerebrovascular events based on nr2 peptides |
| 07/16/2009 | US20090180991 Method for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia |
| 07/16/2009 | DE102008004100A1 New metallocene compounds are estrogen receptor modulators useful e.g. to treat preferably cancer, manic disorder, gynecomastia and/or female infertility, and to prevent mamma carcinoma |
| 07/16/2009 | CA2794054A1 Proline analogs as ligands for cannabinoid receptors |
| 07/16/2009 | CA2727055A1 (1-azinone) -substituted pyridoindoles as mch antagonists |
| 07/16/2009 | CA2711803A1 Pyridine derivatives |
| 07/16/2009 | CA2711675A1 Pharmaceutical compositions and methods utilizing a d-amino acid and an antioxidant for treating neuropsychiatric disorders |
| 07/16/2009 | CA2711652A1 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| 07/16/2009 | CA2711612A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases |
| 07/16/2009 | CA2711605A1 Neuroactive steroid compositions and methods of use therefor |
| 07/16/2009 | CA2711508A1 Proline analogs as ligands for cannabinoid receptors |
| 07/16/2009 | CA2711497A1 Diagnostic and therapeutic methods for efmr (epilepsy and mental retardation limited to females) |
| 07/16/2009 | CA2711466A1 Process for the preparation of sulfamide derivatives |
| 07/16/2009 | CA2711288A1 Lactam inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/16/2009 | CA2711218A1 Microvesicles |
| 07/16/2009 | CA2711160A1 Pterin analog for treating bh4 responsive condition |
| 07/16/2009 | CA2710800A1 Process for the preparation of asenapine and intermediate products used in said process |
| 07/16/2009 | CA2708921A1 Use of cannabinoids in combination with an anti-psychotic medicament |
| 07/16/2009 | CA2707441A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 07/16/2009 | CA2706028A1 Composition comprising a nitrooxyderivative of acetaminophen and a anticonvulsant drug for the treatment of neuropathic pain |
| 07/16/2009 | CA2703824A1 Modulators for amyloid beta |
| 07/16/2009 | CA2702791A1 6-aryl/heteroalkyloxy benzothiazole and benzimidazole derivatives, method for preparing same, application thereof as drugs, pharmaceutical compositions and novel use in particularas c-met inhibitors |
| 07/16/2009 | CA2702012A1 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof |
| 07/16/2009 | CA2692955A1 A new method for preparation of zopiclone and its polymorphs |
| 07/15/2009 | EP2078718A1 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 07/15/2009 | EP2078717A1 6-Pyrimidinyl-pyrimid-2-one derivative |
| 07/15/2009 | EP2078524A1 Adhesive skin patch |
| 07/15/2009 | EP2078024A1 Amorphous asenapine and processes for preparing same |
| 07/15/2009 | EP2078012A2 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
| 07/15/2009 | EP2078009A1 New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90 |
| 07/15/2009 | EP2077999A1 Hydroxamates as inhibitors of histone deacetylase |
| 07/15/2009 | EP2077860A2 Novel psychotropic agents having glutamate nmda activity |
| 07/15/2009 | EP2077852A1 Agent comprising g-csf for prevention and treatment of diabetic peripheral neuropathy |
| 07/15/2009 | EP2077838A2 Methods for the treatment of a related disorders and compositions therefor |
| 07/15/2009 | EP2077836A2 Antidepressant, neuroprotectant, amyloid beta deposition inhibitor or age retardant containing heterocyclic compound |
| 07/15/2009 | EP2077835A2 An alzheimer's disease progression inhibitor containing heterocyclic compound |
| 07/15/2009 | EP2077827A1 Oleanane triterpene saponin compounds which are effective on treatment of dementia and mild cognitive impairment(mci), and improvement of cognitive function |
| 07/15/2009 | EP2077719A2 Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/15/2009 | EP1871738B1 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use |